128 related articles for article (PubMed ID: 5351451)
21. Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1,2,4-trioxolanes.
Dong Y; Tang Y; Chollet J; Matile H; Wittlin S; Charman SA; Charman WN; Tomas JS; Scheurer C; Snyder C; Scorneaux B; Bajpai S; Alexander SA; Wang X; Padmanilayam M; Cheruku SR; Brun R; Vennerstrom JL
Bioorg Med Chem; 2006 Sep; 14(18):6368-82. PubMed ID: 16759871
[TBL] [Abstract][Full Text] [Related]
22. Spirans. XV. Spirans derived from 3-trifluoromethylcyclohexanone.
Rice LM; Sheth BS; Scott KR; Geshickter CF
J Med Chem; 1969 Jan; 12(1):126-30. PubMed ID: 5763008
[No Abstract] [Full Text] [Related]
23. Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonist.
Yang H; Lin XF; Padilla F; Gabriel SD; Heilek G; Ji C; Sankuratri S; deRosier A; Berry P; Rotstein DM
Bioorg Med Chem Lett; 2009 Jan; 19(1):209-13. PubMed ID: 19014885
[TBL] [Abstract][Full Text] [Related]
24. Copper-catalyzed intramolecular trifluoromethylation of N-benzylacrylamides coupled with dearomatization: access to CF3-containing 2-azaspiro[4.5]decanes.
Han G; Liu Y; Wang Q
Org Lett; 2014 Jun; 16(12):3188-91. PubMed ID: 24901480
[TBL] [Abstract][Full Text] [Related]
25. Development of the intramolecular Prins cyclization/Schmidt reaction for the construction of the azaspiro[4,4]nonane: application to the formal synthesis of (±)-stemonamine.
Chen ZH; Tu YQ; Zhang SY; Zhang FM
Org Lett; 2011 Feb; 13(4):724-7. PubMed ID: 21229997
[TBL] [Abstract][Full Text] [Related]
26. Novel spiroanellated 1,2,4-trioxanes with high in vitro antimalarial activities.
Griesbeck AG; El-Idreesy TT; Höinck LO; Lex J; Brun R
Bioorg Med Chem Lett; 2005 Feb; 15(3):595-7. PubMed ID: 15664819
[TBL] [Abstract][Full Text] [Related]
27. Studies on the cholinergic receptor. IV. The synthesis and muscarinic activity of 3,7-dimethyl-2,4-dioxo-7-azaspiro[3.4]octane methiodide.
Ridley HF; Chatterjee SS; Moran JF; Triggle DJ
J Med Chem; 1969 Sep; 12(5):931-3. PubMed ID: 5812223
[No Abstract] [Full Text] [Related]
28. Synthesis of C-xylopyranosyl- and xylopyranosylidene-spiro-heterocycles as potential inhibitors of glycogen phosphorylase.
Somsák L; Bokor É; Czibere B; Czifrák K; Koppány C; Kulcsár L; Kun S; Szilágyi E; Tóth M; Docsa T; Gergely P
Carbohydr Res; 2014 Nov; 399():38-48. PubMed ID: 25081322
[TBL] [Abstract][Full Text] [Related]
29. Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase.
Keith JM; Jones WM; Pierce JM; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Scott BP; Wilson SJ; Luo L; Wennerholm ML; Chang L; Brown SM; Rizzolio M; Rynberg R; Chaplan SR; Breitenbucher JG
Bioorg Med Chem Lett; 2014 Feb; 24(3):737-41. PubMed ID: 24433863
[TBL] [Abstract][Full Text] [Related]
30. Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay.
Gray AN; Ramirez BM; Mawugbe SK; Mar JF; Wong YC; Huang KS
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33645581
[TBL] [Abstract][Full Text] [Related]
31. The total synthesis of spirotenuipesines A and B.
Dai M; Danishefsky SJ
J Am Chem Soc; 2007 Mar; 129(12):3498-9. PubMed ID: 17335213
[No Abstract] [Full Text] [Related]
32. Synthesis and HIV-1 integrase inhibitory activity of spiroundecane(ene) derivatives.
Shults EE; Semenova EA; Johnson AA; Bondarenko SP; Bagryanskaya IY; Gatilov YV; Tolstikov GA; Pommier Y
Bioorg Med Chem Lett; 2007 Mar; 17(5):1362-8. PubMed ID: 17189685
[TBL] [Abstract][Full Text] [Related]
33. A Visible-Light-Mediated Radical Smiles Rearrangement and its Application to the Synthesis of a Difluoro-Substituted Spirocyclic ORL-1 Antagonist.
Douglas JJ; Albright H; Sevrin MJ; Cole KP; Stephenson CR
Angew Chem Int Ed Engl; 2015 Dec; 54(49):14898-902. PubMed ID: 26474077
[TBL] [Abstract][Full Text] [Related]
34. [Reactions of 1,4-pentadien-3-ones. 4. Synthesis and structure of 7,11-diaryl-4,5-benzo-2-azaspiro (5,5) undecane-1,3,9-triones].
Otto HH
Arch Pharm (Weinheim); 1974 Jan; 307(1):58-62. PubMed ID: 4818118
[No Abstract] [Full Text] [Related]
35. Estrogen potentiating activity of two spiro compounds having approximately similar molecular dimensions to stilbestrol.
Doggett NS; Bailey DJ; Qazi T
J Med Chem; 1977 Feb; 20(2):318-20. PubMed ID: 836507
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and central nervous system depressant activity of new oxaza heterocyclic amides.
Pifferi G; Consonni P; Diena A; Rosselli del Turco B
J Med Chem; 1972 Aug; 15(8):851-3. PubMed ID: 5044302
[No Abstract] [Full Text] [Related]
37. One-step synthesis of diazaspiro[4.5]decane scaffolds with exocyclic double bonds.
Li L; Hu Q; Zhou P; Xie H; Zhang X; Zhang H; Hu Y; Yin F; Hu Y
Org Biomol Chem; 2014 Aug; 12(29):5356-9. PubMed ID: 24956492
[TBL] [Abstract][Full Text] [Related]
38. The utilization of spirocyclic scaffolds in novel drug discovery.
Zheng YJ; Tice CM
Expert Opin Drug Discov; 2016 Sep; 11(9):831-4. PubMed ID: 27233084
[No Abstract] [Full Text] [Related]
39. Synthesis of certain spiro compounds.
el-Telbany FA; Ghoneim KM; Khalifa M
Pharmazie; 1976 Jul; 31(7):442-5. PubMed ID: 981296
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and pharmacological screening of certain spiro compounds.
El-Telbany FA; Ghoneim KM; Khalifa
Pharmazie; 1977 Jan; 32(1):22-4. PubMed ID: 320606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
